INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹73 Cr | ₹62 Cr | ₹50 Cr | ₹40 Cr |
What is the latest Revenue of INDO US BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹50 Cr |
| Mar2021 | ₹40 Cr |
How is Revenue of INDO US BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 42.56 | |
| Mar2024 | ₹73 Cr | 17.96 | |
| Mar2023 | ₹62 Cr | 23.36 | |
| Mar2022 | ₹50 Cr | 24.86 | |
| Mar2021 | ₹40 Cr | - | |
Compare Revenue of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹173.7 Cr | -2.5% | -9.4% | -43.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,453.3 Cr | -5.6% | -0.5% | -26.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,983.5 Cr | -1% | 0.4% | -13.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,066.6 Cr | -2.2% | -3.3% | 6.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹954.9 Cr | 3.3% | -6.4% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹550.4 Cr | -0.6% | 2.8% | 14.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2.5% |
-9.4% |
-43.7% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses